{"id":3840,"date":"2025-07-24T16:57:07","date_gmt":"2025-07-24T20:57:07","guid":{"rendered":"https:\/\/www.accessforkidscancer.ca\/?post_type=theme-project&p=3840"},"modified":"2025-07-30T17:14:24","modified_gmt":"2025-07-30T21:14:24","slug":"acces-aux-medicaments-approuves","status":"publish","type":"theme-project","link":"https:\/\/www.accessforkidscancer.ca\/fr\/projects\/acces-aux-medicaments-approuves\/","title":{"rendered":"Acc\u00e8s aux m\u00e9dicaments approuv\u00e9s <\/span>"},"content":{"rendered":"

Le syst\u00e8me canadien d\u2019acc\u00e8s et de remboursement des m\u00e9dicaments comprend une s\u00e9rie d\u2019examens, de recommandations et de d\u00e9cisions qui visent \u00e0 attribuer des ressources publiques limit\u00e9es aux th\u00e9rapies qui offrent le plus d\u2019avantages.\u00a0 En g\u00e9n\u00e9ral, avec des preuves claires de l\u2019innocuit\u00e9, de l\u2019efficacit\u00e9 et de la qualit\u00e9, vous pouvez vous attendre \u00e0 ce que le traitement soit rembours\u00e9 et que les patients y aient acc\u00e8s.\u00a0 C\u2019est particuli\u00e8rement le cas lorsqu\u2019il y a un besoin m\u00e9dical non satisfait et qu\u2019il n\u2019y a pas d\u2019autres th\u00e9rapies approuv\u00e9es.<\/p>\n

Peu de th\u00e9rapies sont \u00e9valu\u00e9es et approuv\u00e9es pour les enfants, y compris pour traiter les cancers p\u00e9diatriques, et la plupart des m\u00e9dicaments utilis\u00e9s pour traiter les enfants sont prescrits sans \u00eatre officiellement approuv\u00e9s. Les enfants atteints de cancer n\u2019ont pas b\u00e9n\u00e9fici\u00e9 de l\u2019explosion des nouveaux m\u00e9dicaments approuv\u00e9s dans les ann\u00e9es 1990 et 2000, y acc\u00e9dant principalement par le biais d\u2019essais cliniques. Il a fallu de nombreuses ann\u00e9es et beaucoup d\u2019efforts pour mener des recherches de suivi et d\u00e9montrer comment ces m\u00e9dicaments agissent chez les enfants, souvent sous la direction de cliniciens universitaires.<\/p>\n

Nous constatons enfin une augmentation des approbations de m\u00e9dicaments contre le cancer chez les enfants, souvent pour des m\u00e9dicaments qui sont sur le march\u00e9 depuis de nombreuses ann\u00e9es.\u00a0 Par exemple, les \u00c9tats-Unis ont fait des progr\u00e8s importants dans l\u2019augmentation du nombre d\u2019approbations de m\u00e9dicaments contre le cancer p\u00e9diatrique par l\u2019interm\u00e9diaire de la FDA, d\u00e9montrant le potentiel d\u2019un cadre plus r\u00e9actif. Il est important de combler les lacunes pour s\u2019assurer que les enfants au Canada ne manquent pas l\u2019acc\u00e8s rapide \u00e0 des th\u00e9rapies efficaces et potentiellement vitales qui sont d\u00e9j\u00e0 disponibles ailleurs.<\/p>\n

Ce projet vise \u00e0 \u00e9valuer syst\u00e9matiquement l\u2019acc\u00e8s aux traitements pour les patients en oncologie p\u00e9diatrique au Canada qui ont obtenu l\u2019approbation r\u00e9glementaire pour une utilisation chez les enfants. Les \u00c9tats-Unis ont la plus longue liste d\u2019indications approuv\u00e9es pour le cancer p\u00e9diatrique \u2013\u00a0cette \u00e9tude examinera le nombre d\u2019indications approuv\u00e9es au Canada, dans l\u2019Union europ\u00e9enne et en Australie. L\u2019\u00e9tude \u00e9valuera \u00e9galement, pour la premi\u00e8re fois, l\u2019\u00e9tat de remboursement public de chacune des indications approuv\u00e9es au Canada.<\/p>\n

Le projet examinera et d\u00e9crira \u00e9galement la fa\u00e7on dont chacune des indications approuv\u00e9es a \u00e9t\u00e9 prise en compte par le \u00ab\u00a0syst\u00e8me\u00a0\u00bb canadien d\u2019examen et d\u2019\u00e9valuation des m\u00e9dicaments.<\/p>\n

Ce travail se d\u00e9roulera en deux phases\u00a0:<\/p>\n

    \n
  1. Cr\u00e9er un ensemble de donn\u00e9es complet sur les m\u00e9dicaments contre le cancer p\u00e9diatrique approuv\u00e9s depuis 2000 par la FDA des \u00c9tats-Unis, Sant\u00e9 Canada, l\u2019Agence europ\u00e9enne des m\u00e9dicaments et la Therapeutic Goods Administration de l\u2019Australie et le statut de remboursement public de chaque indication approuv\u00e9e au Canada.<\/li>\n
  2. D\u00e9crire comment les organismes de r\u00e9glementation canadiens comme Sant\u00e9 Canada, l\u2019Agence canadienne des m\u00e9dicaments et des technologies de la sant\u00e9 (ACMTS) et l\u2019Alliance pharmaceutique pancanadienne (APP) abordent les soumissions p\u00e9diatriques.<\/li>\n<\/ol>\n

    Les produits livrables du projet comprendront un expos\u00e9 de position, un manuscrit \u00e9valu\u00e9 par des pairs et des recommandations strat\u00e9giques concr\u00e8tes pour am\u00e9liorer l\u2019acc\u00e8s aux m\u00e9dicaments en oncologie p\u00e9diatrique au Canada. \u00c0 terme, ce projet transformera la vie des enfants canadiens atteints de cancer et celle de leurs familles, en aidant \u00e0 combler les lacunes en mati\u00e8re d\u2019acc\u00e8s et \u00e0 plaider en faveur de changements r\u00e9glementaires qui refl\u00e8tent mieux les besoins uniques des patients en oncologie p\u00e9diatrique.<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":0,"template":"","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"tags":[],"project-category":[124],"class_list":["post-3840","theme-project","type-theme-project","status-publish","hentry","project-category-acces-a-des-therapies-innovantes-et-a-des-soins-optimaux"],"acf":[],"yoast_head":"\nAcc\u00e8s aux m\u00e9dicaments approuv\u00e9s - Access<\/title>\n<meta name=\"description\" content=\"ACCESS is organized into seven research themes from understanding cancer development to its diagnosis, treatment, and survivorship and two cross-cutting groups to support all thematic areas.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.accessforkidscancer.ca\/fr\/projects\/acces-aux-medicaments-approuves\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acc\u00e8s aux m\u00e9dicaments approuv\u00e9s - Access\" \/>\n<meta property=\"og:description\" content=\"ACCESS is organized into seven research themes from understanding cancer development to its diagnosis, treatment, and survivorship and two cross-cutting groups to support all thematic areas.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.accessforkidscancer.ca\/fr\/projects\/acces-aux-medicaments-approuves\/\" \/>\n<meta property=\"og:site_name\" content=\"Access\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-30T21:14:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.accessforkidscancer.ca\/wp-content\/uploads\/2024\/08\/access-site-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@acces_access\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.accessforkidscancer.ca\/fr\/projects\/acces-aux-medicaments-approuves\/\",\"url\":\"https:\/\/www.accessforkidscancer.ca\/fr\/projects\/acces-aux-medicaments-approuves\/\",\"name\":\"Acc\u00e8s aux m\u00e9dicaments approuv\u00e9s - Access\",\"isPartOf\":{\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/#website\"},\"datePublished\":\"2025-07-24T20:57:07+00:00\",\"dateModified\":\"2025-07-30T21:14:24+00:00\",\"description\":\"ACCESS is organized into seven research themes from understanding cancer development to its diagnosis, treatment, and survivorship and two cross-cutting groups to support all thematic areas.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.accessforkidscancer.ca\/fr\/projects\/acces-aux-medicaments-approuves\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.accessforkidscancer.ca\/fr\/projects\/acces-aux-medicaments-approuves\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.accessforkidscancer.ca\/fr\/projects\/acces-aux-medicaments-approuves\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/www.accessforkidscancer.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acc\u00e8s aux m\u00e9dicaments approuv\u00e9s\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/#website\",\"url\":\"http:\/\/www.accessforkidscancer.ca\/fr\/\",\"name\":\"ACCESS\",\"description\":\"Advancing Childhood Cancer Experience, Science & Survivorship\",\"publisher\":{\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/www.accessforkidscancer.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/#organization\",\"name\":\"ACCESS\",\"url\":\"http:\/\/www.accessforkidscancer.ca\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.accessforkidscancer.ca\/wp-content\/uploads\/2024\/08\/access-organization-logo.png\",\"contentUrl\":\"https:\/\/www.accessforkidscancer.ca\/wp-content\/uploads\/2024\/08\/access-organization-logo.png\",\"width\":696,\"height\":696,\"caption\":\"ACCESS\"},\"image\":{\"@id\":\"http:\/\/www.accessforkidscancer.ca\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/acces_access\",\"https:\/\/www.instagram.com\/access_acces\/\",\"https:\/\/www.linkedin.com\/company\/access-acces\/\",\"https:\/\/www.youtube.com\/channel\/UC0SYgen8vfGlXtikQ8xtQ6A\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acc\u00e8s aux m\u00e9dicaments approuv\u00e9s - Access","description":"ACCESS is organized into seven research themes from understanding cancer development to its diagnosis, treatment, and survivorship and two cross-cutting groups to support all thematic areas.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.accessforkidscancer.ca\/fr\/projects\/acces-aux-medicaments-approuves\/","og_locale":"fr_FR","og_type":"article","og_title":"Acc\u00e8s aux m\u00e9dicaments approuv\u00e9s - Access","og_description":"ACCESS is organized into seven research themes from understanding cancer development to its diagnosis, treatment, and survivorship and two cross-cutting groups to support all thematic areas.","og_url":"https:\/\/www.accessforkidscancer.ca\/fr\/projects\/acces-aux-medicaments-approuves\/","og_site_name":"Access","article_modified_time":"2025-07-30T21:14:24+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.accessforkidscancer.ca\/wp-content\/uploads\/2024\/08\/access-site-image.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@acces_access","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.accessforkidscancer.ca\/fr\/projects\/acces-aux-medicaments-approuves\/","url":"https:\/\/www.accessforkidscancer.ca\/fr\/projects\/acces-aux-medicaments-approuves\/","name":"Acc\u00e8s aux m\u00e9dicaments approuv\u00e9s - Access","isPartOf":{"@id":"http:\/\/www.accessforkidscancer.ca\/fr\/#website"},"datePublished":"2025-07-24T20:57:07+00:00","dateModified":"2025-07-30T21:14:24+00:00","description":"ACCESS is organized into seven research themes from understanding cancer development to its diagnosis, treatment, and survivorship and two cross-cutting groups to support all thematic areas.","breadcrumb":{"@id":"https:\/\/www.accessforkidscancer.ca\/fr\/projects\/acces-aux-medicaments-approuves\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.accessforkidscancer.ca\/fr\/projects\/acces-aux-medicaments-approuves\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.accessforkidscancer.ca\/fr\/projects\/acces-aux-medicaments-approuves\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/www.accessforkidscancer.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Acc\u00e8s aux m\u00e9dicaments approuv\u00e9s"}]},{"@type":"WebSite","@id":"http:\/\/www.accessforkidscancer.ca\/fr\/#website","url":"http:\/\/www.accessforkidscancer.ca\/fr\/","name":"ACCESS","description":"Advancing Childhood Cancer Experience, Science & Survivorship","publisher":{"@id":"http:\/\/www.accessforkidscancer.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/www.accessforkidscancer.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"http:\/\/www.accessforkidscancer.ca\/fr\/#organization","name":"ACCESS","url":"http:\/\/www.accessforkidscancer.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"http:\/\/www.accessforkidscancer.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.accessforkidscancer.ca\/wp-content\/uploads\/2024\/08\/access-organization-logo.png","contentUrl":"https:\/\/www.accessforkidscancer.ca\/wp-content\/uploads\/2024\/08\/access-organization-logo.png","width":696,"height":696,"caption":"ACCESS"},"image":{"@id":"http:\/\/www.accessforkidscancer.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/acces_access","https:\/\/www.instagram.com\/access_acces\/","https:\/\/www.linkedin.com\/company\/access-acces\/","https:\/\/www.youtube.com\/channel\/UC0SYgen8vfGlXtikQ8xtQ6A"]}]}},"_links":{"self":[{"href":"https:\/\/www.accessforkidscancer.ca\/fr\/wp-json\/wp\/v2\/theme-project\/3840","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.accessforkidscancer.ca\/fr\/wp-json\/wp\/v2\/theme-project"}],"about":[{"href":"https:\/\/www.accessforkidscancer.ca\/fr\/wp-json\/wp\/v2\/types\/theme-project"}],"author":[{"embeddable":true,"href":"https:\/\/www.accessforkidscancer.ca\/fr\/wp-json\/wp\/v2\/users\/6"}],"wp:attachment":[{"href":"https:\/\/www.accessforkidscancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=3840"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.accessforkidscancer.ca\/fr\/wp-json\/wp\/v2\/tags?post=3840"},{"taxonomy":"project-category","embeddable":true,"href":"https:\/\/www.accessforkidscancer.ca\/fr\/wp-json\/wp\/v2\/project-category?post=3840"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}